Julio Martin

6PUBLICATIONS
36CO-AUTHORS
ChemotherapyCheminformatics and quantitative structure-activity relationshipsTissue engineeringPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 13, 2023
Short-course combination treatment for experimental chronic Chagas disease.

Silvia González, Richard J Wall, John Thomas

|Jul 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors.

Michael G Thomas, Kate McGonagle, Paul Rowland

|Apr 28, 2022
Essential Bromodomain TcBDF2 as a Drug Target against Chagas Disease.

Alejandro Pezza, Luis E Tavernelli, Victoria L Alonso

|Oct 06, 2021
Expanding Bromodomain Targeting into Neglected Parasitic Diseases.

Cynthia Tallant, Paul Bamborough, Chun-Wa Chung

|Jul 16, 2021
Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box.

Juan Cantizani, Pablo Gamallo, Ignacio Cotillo

|Apr 27, 2021
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis.

Michael Thomas, Stephen Brand, Manu De Rycker

Pageof 1

Frequent Collaborators

3 joint publications

Timothy J Miles

3 joint publications

Manu De Rycker

3 joint publications

Kevin D Read

3 joint publications

Maria Marco